ATC code L
ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
|L Antineoplastic and immunomodulating agents|
|L01 Antineoplastic agents|
|L02 Endocrine therapy|
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
- "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
- "ATC/DDD Index 2021: code L". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2021: code QL". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
/ metabolism (A)
|blood and blood|
forming organs (B)
infestations (J, P, QI)
and joints (M)
nervous system (N)
|sensory organs (S)|
|other ATC (V)|
|CI monoclonal antibodies ("-mab")|
|Tyrosine kinase inhibitors ("-nib")|